// App-Quantinova.ai

2975 : Development of a probody drug conjugate (PDC) targeting CD71 for the treatment of solid tumors and lymphomas

Researchers

Presenter

  • Shweta Singh

Principal Investigators

  • Amy DuPage

  • Annie Yang Weaver

  • Jason Sagert

  • Clayton White

  • Michael Krimm

  • Yuanhui Huang

  • Linnea Diep

  • Kim Tipton

  • Shouchun Liu

  • Jennifer Richardson

  • W. Michael Kavanaugh

  • Jonathan A. Terrett

  • Luc R. Desnoyers

Medical Centers

  • CytomX Therapeutics, South San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Lymphomas

Biomarkers

  • Apparent diffusion coefficient

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved